Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04298229Phase 3Completed
Efficacy and Safety of Dapagliflozin in Acute Heart Failure
Diabetes Mellitus, Type 2Heart Failure
PrincipalinvestigatorStart date: 2020-04-01
NCT07227675Not ApplicableCompleted
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR
Mitral RegurgitationMitral Valve Regurgitation
PrincipalinvestigatorStart date: 2017-10-23
NCT01626079Not ApplicableUnknown
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS
Heart FailureMitral RegurgitationMitral Valve Regurgitation+1 more
PrincipalinvestigatorStart date: 2012-08-01

Research Network

Collaboration Network

8 collaborators·12 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael Mack, MD

Baylor Health Care System

Moderately Similar
2 trials

Shared therapeutic areas:

Mitral Valve InsufficiencyHeart FailureTreatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects

Worked with same sponsors:

Abbott Medical Devices
Collaborated on 2 trials
Similarity Score38%

William T Abraham, MD

The Ohio State University Heart Center

Moderately Similar
2 trials

Shared therapeutic areas:

Mitral Valve InsufficiencyHeart FailureTreatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects

Worked with same sponsors:

Abbott Medical Devices
Collaborated on 2 trials
Similarity Score38%

Gregg Stone, MD

MOUNT SINAI HOSPITAL

Moderately Similar
3 trials

Shared therapeutic areas:

Heart FailureMitral Valve InsufficiencyTreatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects

Worked with same sponsors:

Abbott Medical Devices
Collaborated on 1 trial
Similarity Score34%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Heart Failure
Similarity Score15%

Robert J Lederman, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
17 trials

Shared therapeutic areas:

Heart FailureMitral Valve Insufficiency
Similarity Score15%

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Heart Failure
Similarity Score15%

Gregg W Stone,, MD

MOUNT SINAI HOSPITAL

Related
1 trials

Shared therapeutic areas:

Mitral Valve Insufficiency

Worked with same sponsors:

Abbott Medical Devices
Collaborated on 1 trial
Similarity Score14%

Paolo Bonato, PhD

Spaulding Rehabilitation Hospital

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score8%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Heart Failure
Similarity Score8%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04298229Phase 3PrincipalInvestigator

Efficacy and Safety of Dapagliflozin in Acute Heart Failure

Diabetes Mellitus, Type 2Heart Failure
Completed
NCT07227675Not ApplicablePrincipalInvestigator

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR

Mitral RegurgitationMitral Valve Regurgitation
Completed
NCT01626079Not ApplicablePrincipalInvestigator

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS

Heart FailureMitral RegurgitationMitral Valve Regurgitation+1 more
Unknown

All 3 trials loaded